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ABSTRACT 
 
 In previous studies, we showed that the pro-oxidant model agent tert-butyl 
hydroperoxide (tBuOOH) induces alterations in hepatocanalicular secretory function by 
activating Ca2+-dependent protein kinase C isoforms (cPKC), via F-actin disorganization 
followed by endocytic internalization of canalicular transporters relevant to bile formation 
(Mrp2, Bsep). Since mitogen-activated protein kinases (MAPKs) may be downstream 
effectors of cPKC, we investigated here the involvement the MAPKs of the ERK1/2, 
JNK1/2, and p38MAPK types in these deleterious effects. tBuOOH (100 µM, 15 min) 
increased the proportion of the active, phosphorylated forms of ERK1/2, JNK1/2, and 
p38MAPK, and panspecific PKC inhibition with bisindolylmaleimide-1 (100 nM) or selective 
cPKC inhibition with Gö6976 (1 μM) prevented the latter two events. In isolated rat 
hepatocyte couplets, tBuOOH decreased the canalicular vacuolar accumulation of the 
fluorescent Bsep and Mrp2 substrates, cholylglycylamidofluorescein and glutathione-
methylfluorescein, respectively, and selective inhibitors of ERK1/2 (PD098059), JNK1/2 
(SP600125), and p38MAPK (SB203580) partially prevented these alterations. In in situ 
perfused rat livers, these three MAPK inhibitors prevented tBuOOH (75 µM)-induced 
impairment of bile flow, and the decrease in the biliary output of the Bsep and Mrp2 
substrates, taurocholate and dinitrophenyl-S-glutathione, respectively. The changes in 
Bsep/Mrp2 and F-actin localization induced by tBuOOH, as assessed by 
(immuno)fluorescence staining followed by analysis of confocal images, were prevented 
total or partially by the MAPK inhibitors. We concluded that MAPKs of the ERK1/2, 
JNK1/2, and p38MAPK types are all involved in cholestasis induced by oxidative stress, by 
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promoting F-actin rearrangement and further endocytic internalization of canalicular 
transporters critical for bile formation. 
 
KEYWORDS: Oxidative stress, hepatocellular cholestasis, canalicular transporters, 
mitogen-activated protein kinases, actin cytoskeleton. 
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INTRODUCTION 
 Oxidative stress (OS) is a common feature in most hepatopathies, including drug 
and environmental toxin-induced hepatotoxicity, hepatic ischemia-reperfusion injury, viral 
and autoimmune hepatitis, alcoholic and non-alcoholic steatohepatitis, and pathologies 
leading to hepatic accumulation of either heavy metals, such as iron (hemochromatosis) and 
copper (Wilson´s disease), or bile acids (obstructive or functional cholestasis) (Copple 
2010; Jaeschke 2002). 
 In recent years, evidence has accumulated that, in cholestatic hepatopathies, a 
vicious circle occurs, since OS is cholestatic in nature, thus aggravating the initial secretory 
failure (Roma 2008). Indeed, our group demonstrated in isolated rat hepatocyte couplets 
(IRHCs) that OS induces rapid endocytic internalization of the bile salt export pump (Bsep, 
AKA: Abcc11) (Perez 2006b), the main canalicular bile salt transporter. A similar 
phenomenon was described for multidrug resistance-associated protein 2 (Mrp2, Abcc2) 
(Schmitt 2000; Sekine 2011; Ji 2004), another canalicular transporter highly relevant to bile 
formation by mediating the biliary excretion of glutathione, another main driving force of 
bile formation. 
 We also showed a close link between internalization of canalicular transporters and 
actin cytoskeleton disarrangement, an alteration that has been shown to onset canalicular 
transporter endocytosis (Rost 1999). Under OS conditions, actin redistributes from the 
pericanalicular zone to the rest of cell body, through a mechanism involving calcium-
dependent isoenzymes of protein kinase C (cPKC) (Perez 2006a, b); this may occur via 
both an increase of intracellular calcium levels (Stone 1994) and a direct activation of 
cPKC via oxidative modifications (Cosentino-Gomes 2012). 
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 The exact mechanisms that explain the deleterious effect of cPKC on actin integrity 
and, by extension, on the hepatocanalicular function have not been yet elucidated. PKC 
may activate downstream signaling pathways able to intermediate cytoskeletal 
perturbations, and the signaling pathways mediated by mitogen-activated protein kinases 
(MAPKs) are likely candidates; our previous finding that PKA activation counteracts OS-
induced hepatocanalicular dysfunction (Perez 2006a, b) also points to MAPKs, since PKA 
exerts inhibitory cross-talk on MAPK activation (Cook 1993). 
 MAPKs are evolutionarily conserved serine/threonine-specific protein kinases 
involving three major subfamilies, namely extracellular signal-regulated kinases (ERK1/2, 
ERK3/4, ERK5, ERK7/8), Jun N-terminal kinases (JNK1/2/3), and p38MAPK (p38MAPK 
α/β/γ/δ) (Kyriakis 2012). They respond to a wide range of hormones and extracellular 
stressors, including OS (Kyriakis 2012). After recognition of these effectors by surface 
receptors, MAPKs are activated by three-tiered, sequential phosphorylations mediated by 
small GTP-binding proteins (e.g., Ras, Rap) and two further protein kinases (MAPKKK 
and MAPKK), which act as dual-specificity enzymes that activate a selective MAPK type. 
Non-canonical activation of MAPKs also exists, via either MAPK autophosphorylation or 
direct MAPK phosphorylation by alternative protein kinases, such as Src or ZAP70 
(Pimienta 2007). 
 Activation of MAPKs are triggered by OS in most organs, including liver (Kyriakis 
2012). Radical oxygen species (ROS) from different sources induced ERK1/2, JNK1/2, and 
p38MAPK activation in murine hepatocytes (Rosseland 2005; Conde de la 2006; 
Abdelmegeed 2004), as well as in hepatoma cell lines (Nguyen 2013; Liu 2011). Similarly, 
PKC can activate MAPKs in hepatocytes (Romanelli 1997), an effect that is thought to be 
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mediated by Ras (Malumbres 1998). More relevant to our case, MAPKs are activated by 
PKC under OS conditions in hepatocytes (Lee 2008; Gao 2004). 
 This prompt us to hypothesize that MAPKs are involved in OS-induced, cPKC-
mediated impairment of the hepatocalicular function and cholestasis. To confirm this 
contention, we analyzed the role for MAPKs in cholestasis induced by the pro-oxidizing 
compound tBuOOH, in two in vitro models for the study of biliary secretion, namely 
IRHCs and in situ perfused rat livers (PRLs). tBuOOH is a short chain analogue of lipid 
peroxides widely used to mimic the deleterious effect lipid peroxides produced during the 
OS-induced lipid oxidation cascade; like endogenous lipid peroxides, tBuOOH generate, 
after metabolic activation, peroxyl and alkoxyl radicals, with the former being most likely 
involved in cholestatic effects (Ahmed-Choudhury 1998). 
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MATERIALS AND METHODS 
 
Materials. 
 Collagenase type A (from Clostridium histolyticum), bovine serum albumin 
(fraction V), tBuOOH, dimethyl sulfoxide (DMSO), 1-chloro-2,4-dinitrobenzene (CDNB), 
sodium taurocholate, trypan blue, Leibovitz-15 (L-15) culture medium, ethylene glycol 
tetraacetic acid, tetramethylethylenediamine, urethane, phenylmethylsulfonyl fluoride 
(PMSF), reduced nicotinamide adenine dinucleotide phosphate, and Triton X-100 were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). 5-Chloromethylfluorescein 
diacetate (CMFDA), Alexa Fluor 568 phalloidin were from Molecular Probes (Eugene, OR, 
EE.UU.). Gö6976, bisindolylmaleimide-1 (BIM-1), PD980589, SB203580, and SP600125 
were from Calbiochem (San Diego, CA, EE.UU.). Dulbecco´s Modified Eagle Medium 
(DMEM) culture medium was from Life Technologies (Grand Island, NY, EE.UU.). Rabbit 
antimouse Bsep (1:100) antibody was from Kamiya (Seattle, Washington, USA). Primary 
anti-MRP2 antibody (M2 III-6 clone) was from Alexis Biochemicals (San Diego, CA, 
EE.UU.). Secondary, horseradish peroxidase (HRP)-conjugated anti-rabbit IgG and anti-
mouse IgG antibodies, chemiluminescent substrate for HRP, and Hyperfilm ECL were 
from Thermo Fisher Scientific Inc. (Waltham, MA, EE.UU.). Secondary, Cy2-conjugated 
anti-rabbit and anti-mouse IgG antibodies were from Jackson InmunoResearch 
Laboratories, Inc (Filadelfia, EE.UU.). Mouse anti-p38MAPK and rabbit anti-phosphorylated 
p38MAPK were from Santa Cruz Biotechnology (Santa Cruz, CA, EE.UU.). Rabbit anti-
phosphorylated ERK1/2, rabbit anti-ERK1/2, rabbit anti-JNK1/2, and mouse anti-
phosphorylated JNK1/2 antibodies were from Cell Signaling Technology (Danvers, MA, 
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EE.UU.). Cholylglycyl amidofluorescein (CGamF) was kindly donated by Prof. Alan 
Hofmann (University of California, San Diego, CA, EE.UU.). All the other reagents were 
of the highest purity commercially available. 
 
Animals. 
 Adult male Wistar rats weighing 300-350 g (8- to 10-weeks-old) were used 
throughout. Animals were maintained on a standard diet and water ad libitum, and housed 
in a temperature- and humidity-controlled room under a constant 12-hour light, 12-hour 
dark cycle. Treatments were carried out under urethane anesthesia (1 g/kg, i.p.). All animals 
received humane care according to the criteria outlined in the “Guide for the Care and Use 
of Laboratory Animals”, by the National Academy of Sciences and published by the 
National Institutes of Health (NIH publication 25-28, revised 1996).  
 
Western blot analysis of MAPK phosphorylation 
Activation of p38MAPK, ERK1/2, and JNK1/2 was assessed by evaluating by Western 
blotting the phosphorylation status of these MAPKs in lysates of primary-cultured rat 
hepatocytes. Briefly, isolated rat hepatocytes were obtained by collagenase perfusion, as 
described elsewhere (Berry 1969), and cultured in 3-cm Petri dishes with DMEM medium 
supplemented with 10% FCS and antibiotics (penicillin, streptomycin), at the density of 2 x 
106 cells/mL. After 24 hs of culture, cells were exposed to tBuOOH (100 µM) for 5, 15, 
and 30 min, or for 15 min in cells pretreated for 15 min with the cPKC inhibitor Gö6976 (1 
µM) (Perez 2006a, b) or the panspecific PKC inhibitor BIM-1 (100 nM) (Zegers 1997), 
washed with cold phosphate-buffered saline, and finally resuspended in cell lysis buffer and 
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protease inhibitor cocktail. Aliquots containing equivalent total protein content, as 
determined by the Lowry procedure with BSA as the standard (Lowry 1951), were 
subjected to sodium dodecyl sulfate/12% polyacrylamide gel electrophoresis, 
electrotransferred to Immobilon-P membranes and probed overnight with rabbit anti-
phosphorylated p38MAPK (1:300), rabbit anti-phosphorylated ERK1/2 (1:1000), and mouse 
anti-phosphorylated JNK1/2 (1:2000) antibodies. Stripped membranes were reprobed with 
rabbit anti-total p38MAPK (1:1000), rabbit anti-total ERK1/2 (1:1000), and mouse anti-total 
JNK1/2 (1:1000) antibodies. After exposure to donkey anti-rabbit IgG secondary antibody 
or a goat anti-mouse IgG (1:5000, 1 h; Thermo Fisher Scientific, Waltham, MA, USA), 
protein bands were visualized using a chemiluminescence reagent (ECL™-GE Healthcare, 
USA) and captured with Hyperfilm ECL™ (GE Healthcare, Amersham, USA); the 
autoradiography film was manually scanned, and the densitometry data were obtained by 
using the ImageJ 1.34m software (NIH, USA). 
 
Studies in isolated rat hepatocyte couplets 
Couplets isolation, enrichment, culture, and treatments. IRHCs were obtained according to 
the two-step collagenase perfusion procedure, followed by centrifugal elutriation (Wilton 
1991). The resulting preparation, containing 70 ± 4% of couplets of high viability (>95%), 
was plated onto 24-well plastic plates, at a density of 5 x 104 units/ml, and incubated at  
37 ºC for 4.5 h, for attachment and repolarization. Then, IRHCs were incubated with 
tBuOOH (100 M, 15 min), or DMSO (vehicle; 0.2-0.5 % v/v) in controls; at the 100 M 
concentration, tBuOOH had been shown to impair by ~50% the Bsep-mediated canalicular 
transport function in IRHCs (Ahmed-Choudhury 1998), whereas 0.5 % v/v DMSO was 
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without effect on this parameter (Perez 2006a), and on blebbing/actin organization (Perez 
2006b). 
 To assess the involvement of MAPK in the deleterious effect induced by tBuOOH, 
the MAPK inhibitors SB203580 (1 µM, p38MAPK inhibitor), PD098059 (50 µM, MEK 
inhibitor) or SP600125 (1 µM, JNK inhibitor) was added to the culture medium for 15 min 
prior to exposure to tBuOOH, and kept further during the exposure to this pro-oxidant 
compound. 
Assessment of biliary secretory function in IRHCs. Bsep function was evaluated by 
assessing the proportion of couplets (> 200 per preparation) displaying canalicular vacuolar 
accumulation (CVa) of the fluorescent bile salt analog CGamF, a fluorescent Bsep substrate 
(Maglova 1995), as described previously (Basiglio 2014). Similarly, Mrp2 function was 
evaluated through its ability to secrete glutathione-S-methylfluorescein (GS-MF), the 
fluorescent glutathione-conjugated metabolite of CMFDA; this latter compound diffuses 
passively, and is intracellularly metabolized by esterases and glutathione S-transferases to 
render GS-MF (Roelofsen 1998). 
Assessment of bleb formation. Blebbing, a preliminary marker of F-actin cytoskeleton 
disruption (Gores 1990), was quantified using light microscopy, by assessing the proportion 
of IRHCs exhibiting at least one bleb in either of the two cells, referred to the total number 
of IRHCs analyzed (> 50) (Stone 1994). 
Bsep, Mrp2, and F-actin localization. Bsep and Mrp2 immunostaining was carried out as 
described elsewhere (Crocenzi 2008). Briefly, paraformaldehyde-fixed IRHCs were 
incubated with antibodies to Bsep or Mrp2 (1:100) for 2 h, followed by incubation with 
Cy2-labeled anti-rabbit (or anti-mouse) IgG goat antibody (1:200), or with Alexa Fluor 568 
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phalloidin for F-actin, for a further 40-min period. Densitometric analysis of confocal 
images taken with a Zeiss Pascal LSM 5 (Carl Zeiss, Walldorf, Germany) was carried out 
to assess the localization of both Bsep/Mrp2 and F-actin. The canalicular vacuole was 
delimited by superposing each fluorescence image with its respective differential interface 
contrast (DIC) image (Boaglio 2012). Intensity of Bsep/Mrp2-associated fluorescence was 
quantified along an 8-µm line perpendicular to the canalicular vacuole (from -4 µm to  +4 
µm of the canalicular center), as described elsewhere (Boaglio 2012). The proportion of F-
actin confined in its normal pericanalicular localization was also quantified. For this 
purpose, this pericanalicular region was delimited by determining the area surrounding the 
bile canaliculi of control IRHCs where the pixels had a F-actin-associated fluorescence 
intensity at least twice of that of the background. This area was no wider than 1 µm, a value 
close to that reported elsewhere (Serriere 2008). 
 
Studies in PRLs. 
Rat liver perfusion. Livers from bile duct-cannulated rats (Intramedic PE-10 tubing, Clay 
Adams) were perfused in situ in a non-recirculating system, as described elsewhere 
(Crocenzi 2008). Experiments exhibiting lactate dehydrogenase activities  
> 20 U/L in the perfusate outflow were considered unviable. 
 After a 20-min stabilization period, SB203580 (250 nM), PD98059 (5 µM), 
SP600125 (1 µM), or their solvent, DMSO, was added, and allowed to act throughout the 
whole perfusion period. After 15 min of pretreatment with each MAPK inhibitor, tBuOOH 
(or DMSO) was added to the reservoir at a 75 µM concentration, and allowed to act for a 
further 10-min period. Finally, tBuOOH perfusion was stopped, and the livers were 
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perfused only with each of the MAPK inhibitors. Bile was collected at 10-min intervals 
throughout the experiment. 
 Bile flow was estimated gravimetrically. We also calculated the outputs of the Bsep 
substrate taurocholate (added to the reservoir at a 2.5 M concentration) and of the Mrp2 
substrate 2,4-dinitrophenyl-S-glutathione (DNP-SG), produced intracellularly by 
glutathione conjugation of CDNB (added to the reservoir at a 0.5 M concentration). 
Taurocholate was assessed in bile by the 3-hydroxysteroid dehydrogenase procedure 
(Talalay 1960). Biliary DNP-SG was determined by HPLC, as described elsewhere 
(Mottino 2001). At the end of the experiment, livers were removed, sections were rapidly 
frozen in dry-ice-chilled isopentane, and stored at -70ºC, until use. 
Immunohistochemical detection of Bsep, Mrp2 and F-actin. Confocal microscopy was used 
to visualize Bsep/Mrp2 endocytic internalization and F-actin disorganization, as previously 
described (Basiglio 2014). Briefly, liver slices (5 µm) were prepared with a Zeiss Microm 
HM500 microtome cryostat, and fixed for 10 min with 3% paraformaldehyde, in PBS. For 
Bsep and Mrp2 labeling, tissue sections were incubated overnight with the specific 
antibody to Bsep or Mrp2 (1:100). Sections were then incubated with Cy2-conjugated 
donkey anti-rabbit IgG (1:100) and Alexa Fluor 568 phalloidin (for F-actin staining), for 1 
h. Then, slices were mounted, and analyzed by confocal microscopy. 
 
Statistical analysis. 
 Statistical analysis was performed by using GraphPad Prism software (GraphPad, 
San Diego, CA, USA). Results were expressed as mean ± S.E.M. When requirements for 
parametric analysis were met, a Student’s unpaired t test was used for comparison between 
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two groups; comparisons between two groups that did not meet this criterion were carried 
out using the Mann-Whitney’s rank sum test. Multiple groups were compared by one-way 
analysis of variance (ANOVA) or, when normality test failed, by non-parametric Kruskal-
Wallis’ test (one-way ANOVA by ranks). If ANOVA reached any statistical significance 
among groups, pairwise multiple comparisons were carried out by using Tukey's or Dunn's 
tests, respectively. The variances of the densitometric profiles of Bsep and Mrp2 
localization were compared with the Mann-Whitney U test. p values lower than 0.05 were 
judged to be significant. 
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RESULTS 
 
MAPK activation by tBuOOH, and dependency on cPKC. 
 The time course of p38MAPK, ERK1/2 and JNK1/2 after exposure of cultured rat 
hepatocytes to tBuOOH, as determined by the increase in the phosphorylated, active forms 
of these enzymes, is shown in Fig. 1 A. Western blots of phospho- (p)-ERK1/2, p-JNK1/2, 
and, p-p38MAPK showed that tBuOOH increased the amount of the each p-MAPK in a time-
dependent manner, with increments becoming apparent by 5 min after tBuOOH exposure. 
 As shown in Fig. 1 B, pretreatment with the cPKC inhibitor Gö6976 selectively 
prevented the increase in p-p38MAPK and p-JNK1/2, but no that of p-ERK1/2, indicating 
that activation of p38MAPK and JNK1/2 depends upon cPKC, whereas activation of ERK1/2 
depends on an alternative, unidentified redox-sensitive signaling pathway. To control for 
putative Gö6976 inhibitory unspecificity towards other redox-sensitive kinases, the 
structurally and mechanistically unrelated PKC inhibitor bisindolylmaleimide-1 (BIM-1) 
was assayed as well, and they inhibited p38MAPK and JNK1/2 to the same extent as Gö6976. 
 
MAPKs play a role in tBuOOH-induced impairment of function and localization of Bsep 
and Mrp2 in IRHCs.  
 The percentage of couplets able to accumulate in their canalicular vacuoles the 
fluorescent Bsep and Mrp2 substrates CGamF and GS-MF, respectively, is shown in Fig. 2. 
Control couplets exposed only to DMSO (tBuOOH vehicle) showed a 65-70% CVa of each 
fluorescent substrate. While tBuOOH caused a decrease in the percentage of couplets 
accumulating apically both fluorescent substrates, pre-treatment with the JNK1/2 inhibitor 
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SP600125 (1 µM), the ERK inhibitor PD098059 (5 µM and 50 µM), and the p38MAPK 
inhibitor SB203580 (1 µM) partially prevented these effects. None of these inhibitors 
modified the apical accumulation of both substrates per se (Supplementary Table 1). 
 Confocal immunolocalization studies in control IRHCs showed that both Bsep and 
Mrp2 were mainly confined to the canalicular membrane, while tBuOOH induced 
relocalization of Bsep and Mrp2 into intracellular vesicles, indicating endocytosis (Fig. 3, 
upper graphs of panels A and B, respectively). All the MAPKs inhibitors partially prevented 
this effect. 
 These findings were confirmed by densitometric analysis. Densitometric curves 
showed a flatter Bsep and Mrp2 fluorescence profile in tBuOOH-treated IRHCs, as 
compared to controls (Fig. 3, lower graphs of panels A and B, respectively). In IRHCs 
pretreated with either of the MAPK inhibitors, densitometric curves were statistically less 
flat than that of tBuOOH alone (p<0.05). 
 
MAPKs are involved in tBuOOH-induced blebbing and F-actin redistribution. 
 Bleb formation was assessed as a preliminary marker of cytoskeleton disruption 
(Gores 1990), by phase-contrast microscopy. As shown in Fig. 4 A, control cells exposed 
only to the tBuOOH solvent, DMSO, showed a low background blebbing (< 18%), which 
consisted usually of a single, small bleb per cell (type 1 blebbing). In contrast, tBuOOH 
induced extensive bleb formation, often visualized as multiple membrane protrusions 
distributed all over the cell surface (type 2 blebbing). Individual pretreatment with all the 
MAPK inhibitors fully prevented this effect. None of these inhibitors induced blebbing per 
se (Supplementary Table 1) 
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 F-actin distribution was also analyzed by confocal microscopy under the same 
conditions (Fig. 4 B). In control IRHCs, F-actin displayed a predominant pericanalicular 
localization, forming a dense belt beneath the canalicular membrane. In tBuOOH-treated 
IRHCs, bleb formation was accompanied by extensive redistribution of F-actin from the 
pericanalicular area to the sinusoidal plasma membrane region. Redistribution of F-actin 
was extensively prevented by pretreatment of IRHCs with either of the MAPK inhibitors.  
 
tBuOOH induces cholestasis by a MAPK-mediated mechanism in PRLs. 
 Livers were perfused first with tBuOOH (75 µM) for 10 min, in the presence or 
absence of the JNK1/2 inhibitor SP600125, the ERK inhibitor PD098059, and the p38MAPK 
inhibitor SB203580 (Fig. 5); 75 µM tBuOOH closely reproduced the extent of bile salt 
secretory failure reached in IRHCs exposed to 100 µM tBuOOH. 
 Initial exposure of PRLs to the MAPK inhibitors did not significantly influenced 
bile flow. On the other hand, bile flow dropped sharply after the onset of tBuOOH 
perfusion, with a nadir to ~60% of control values at 20 min, and a trend towards recovery 
of bile flow afterwards; this is likely due to both the efficient reductive detoxification of 
tBuOOH (Rush 1986) and the further spontaneous recovery of actin organization and 
canalicular transport function, which was shown to occur quickly in the IRHC model (Pérez 
2006a, b). All the MAPK inhibitors significantly prevented this bile flow decrease, with 
bile flow profiles approaching that of control (Fig. 5 A). 
 Since Bsep and Mrp2 are key determinants of bile flow, we assessed the capability 
of the MAPK inhibitors to prevent their functional impairment induced by tBuOOH. The 
pro-oxidant induced a ~85% and a ~60% of decrease in the excretion of the Bsep and Mrp2 
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substrates taurocholate and DNP-SG, respectively, but this effect was prevented when the 
MAPK inhibitors were present (Fig. 5 B and C, respectively). 
 
MAPKs are involved in the changes of Bsep, Mrp2, and F-actin localization induced by 
tBuOOH. 
 Tissue sections obtained from PRLs after 20 min of the onset of tBuOOH exposure 
were subjected to co-staining of Bsep and F-actin, or Mrp2 and F-actin. In control livers, 
transporter-associated fluorescence was confined to the canalicular space (Fig. 6). In 
tBuOOH-treated livers, the carriers relocalized from the canalicular space to the 
pericanalicular, as indicated by the increased fluorescence at a greater distance from the 
bile canaliculus. Exposure to ERK1/2, JNK1/2 and p38MAPK inhibitors significantly 
prevented these alterations. 
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DISCUSSION 
 In previous works, we demonstrated that tBuOOH induces alterations in the 
secretory function in IRHCs via activation of cPKC, through a mechanism that involve 
disorganization of the F-actin cytoskeleton, and subsequent endocytic internalization of 
canalicular transporters responsible for bile formation, Bsep and Mrp2 (Perez 2006a, b). In 
this work, we extended this finding by showing that MAPKs of the ERK1/2, JNK1/2, and 
p38MAPK types are all involved in OS-induced cholestasis as well, and that, for JNK1/2 and 
p38MAPK, cPKC is an upstream activator. On the other hand, ERK1/2 activation by 
tBuOOH does not seem to be mediated by cPKC; this is in line with the finding that 
ERK1/2 was activated by hydrogen peroxide via Ca2+- and PKC-independent mechanisms 
in cardiomyocytes, involving instead the Src family of tyrosine kinases Ras and Raf-1 
(Aikawa 1997). Another possible redox sensitive kinase that can be involved upstream of 
ERK1/2 is apoptosis stimulating kinase 1 (ASK-1), a serine/threonine kinase of the MKKK 
family; ASK1 can be activated by ROS-mediated oxidation of its physiological inhibitor, 
thioredoxin, with whom ASK1 forms an inactive complex (Saitoh 1998). 
 Whether these MAPKs directly phosphorylates cytoskeletal proteins to induce F-
actin relocalization and further impairment in canalicular transporter localization is 
unknown. There is accumulating evidence in other epithelial cell types that this may be the 
case. For example, ethanol induced disruption of F-actin and the subsequent opening of 
intercellular tight junctions through oxidative mechanisms in Caco-2 cells, a polarized in 
vitro model of intestinal epithelium (Elamin 2014) and, as in our case, the MAPKs of the 
p38MAPK, ERK1/2, and JNK1/2 types need to be all active for this deleterious effect to 
occur. The event also involved the phosphorylation of myosin light chain kinase (MLCK), 
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which favors the formation of crosslinks with F-actin by phosphorylating myosin light 
chain (MLC); once phosphorylated, MLC generates a myosin-F-actin contractile force, 
with the resulting increase in cytoplasm tension and bleb formation (Elamin 2014). It has 
also been shown in livers subjected to ischemia/reperfusion that p38MAPK induces activation 
of heat shock protein 27 (HSP27) (Keller 2005), a protein that promotes the formation of 
crosslinks between F-actin and myosin by inhibiting the phosphorylation of caldesmon, a 
physiological inhibitor of the myosin-F-actin interaction (Somara 2006). In addition, 
ERK1/2 may directly phosphorylate caldesmon in vivo, thus reinforcing this effect (Hedges 
2000). A similar phenomenon was reported in the human liver cell line HL7702 exposed to 
the phosphatase 2A inhibitor microcystin-LR, a toxin that promotes cytoskeletal 
reorganization by inducing p38MAPK- and JNK1/2-mediated phophorylation of HSP27 (Sun 
2011). In a pro-apoptotic context, MLC phosphorylation and the resulting bleb formation 
may also be mediated by the serine/threonine protein kinase ROCK I, which is activated by 
caspase-3-dependent cleavage (Sebbagh 2001). Although apoptosis is a well recognized 
event in hepatocytes exposed to high tBuOOH concentrations (Toledo 2014; Salkar 2010; 
Tripathi 2009), at the low concentration used here (100 µM), tBuOOH showed no sign of 
caspase-3 activation, as well as of other hallmarks of apoptosis, such as appearance of 
nuclei with subdiploid DNA content and cytochrome-c release (Gómez-Lechón 2002). 
However, bleb formation may precede these apoptotic changes (Barros 2003), and therefore 
we cannot rule that the blebbing and consequent canalicular dysfunction occurring at low 
tBuOOH levels may represent a very early event of an ongoing apoptotic process. 
Interestingly, Deschesnes et al. (2001) showed that blebbing in c-Myc–dependent apoptosis 
of rat-1 cells was independent of caspase activity, but depended on p38MAPK-sensitive 
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changes in microfilament dynamics, likely mediated by HSP27 phosphorylation. The 
functional status of canalicular transporters during the apoptotic process and its relationship 
with the cytoskeletal perturbations induced by OS is a pending, intriguing issue that 
deserves further investigation. 
 MAPKs could also change canalicular transporter location by activating 
mechanisms leading to radixin phosphorylation. Expression of constructs that mimic a 
permanently phosphorylated (active) form of radixin in the polarized, hybrid 
hepatoblastoma/human fibroblast cell line WIF-B led to redistribution of radixin from the 
canalicular to the basolateral membrane, probably as a consequence of a more promiscuous 
interaction of its active, phosphorylated form with both apical and basolateral pools of F-
actin; this would lead to relocation of the canalicular transporters (Suda 2011). 
Furthermore, activation of radixin by p38MAPK-dependent phosphorylation of Thr-564 has 
been shown in several cell lines, through a signaling mechanism which, like in our case, 
involves PKC activation (Zhang 2014; Bogatcheva 2011). Contrarily to this view, an 
impaired rather than an enhanced phosphorylation of radixin has been proposed to account 
for Mrp2 endocytosis under OS conditions in IRHCs; this would involve protein 
phosphatase PP-1-dependent dephosphorylation of radixin via PKC-induced PP-1 
activation, leading to instability of Mrp2 in the plasma membrane by loss of cross-linking 
with actin filaments (Sekine 2011). This latter view is somewhat difficult to reconcile with 
our finding of significant ERK1/2 activation, since PP-1 was shown to prevent this 
activation presumably by dephosphorylation of the upstream enzymes, MEK and Raf 
(Schaeffer 1999). 
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 MAPK dependence of tBuOOH-induced cholestasis is somewhat paradoxical with 
previous works showing that ERK1/2 and p38MAPK are both involved in choleretic 
phenomena, such as those induced by tauroursodeoxycholate (TUDC) (Kurz 2001; Schliess 
1997; Kubitz 2004) and cAMP (Schonhoff 2010). For example, TUDC stimulates excretion 
of the choleretic bile salt taurocholate via an integrin-dependent signaling pathway 
involving both Ras/Raf/MEK/ERK1/2 and Src/p38MAPK (Häussinger 2003), as a result of 
stimulation of the Bsep trafficking from Golgi to the canalicular membrane (Kubitz 2004). 
The reason for the paradoxical mediation of MAPKs of opposite (choleretic and 
cholestatic) effects on bile flow under normal and oxidative conditions, respectively, is 
unclear at present, but could be linked to the following reasons: 
1) MAPKs activation is highly compartmentalized, requiring localization at specific sites of 
scaffold proteins to allow regional recruitment of the multiple components of the MAPK 
cascade (Canal 2011). In quiescent hepatocytes, Raf-1 and MEK are located only in early 
endosomes, which are the first endosomal compartment to receive endocytosed transporters 
(Pol 1998). Therefore, the rapid cholestatic effects induced by tBuOOH in our acute 
exposure model may involve events limited to "early" compartment, such as endocytosis of 
transporters to subapical endosomes. Contrarily, the choleretic effects involving trafficking 
of transporters from Golgi/post-Golgi compartments to the canalicular membrane would be 
a later event, occurring when trafficking of scaffold proteins to deeper levels is stimulated 
by the choleretic stimulus (Philips 2004). 
2) The different array of activated/inhibited signaling cascades occurring in an oxidative 
context may result, when operating in concert with MAPKs, in opposite effects on bile 
secretion, as compared to those occurring in the normal cellular context where choleresis 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
22 
 
occurs. A similar paradoxical phenomenon was shown by us for the cholestatic agent 
estradiol 17ß-glucuronide, which also required cPKC-dependent MAPK activation to 
induce cholestasis (Boaglio 2012). 
3) Choleretic and cholestatic compounds (in this case, tBuOOH) might activate MAPK 
isoforms with opposite effects on bile flow. For example, α- and β-p38MAPK isoforms 
mediate choleretic and cholestatic effects of bile salts, respectively (Anwer 2012; 
Schonhoff 2010). 
4) As shown here, the three MAPK types need to be activated simultaneously by tBuOOH 
to exert its cholestatic effects, and this may not be the case for choleretic compounds; for 
example, the choleretic bile salt TUDC activates p38MAPK and ERK1/2, but not JNK1/2 
(Kurz 2001). 
 Although more studies are needed to determine with certainty the molecular 
mechanisms by which the MAPKs induced cholestasis when activated in an oxidative 
context, our results show that the interaction of MAPKs with actin cytoskeleton is critical 
for the endocytic internalization of canalicular carriers relevant for bile formation, thus 
explaining the cholestatic phenomenon. Drugs that selectively inhibit MAPKs are used in 
preclinical and clinical studies with reasonable success (Chapman 2011). Given the 
existence of clinical cholestatic liver diseases in humans associated with high levels of OS, 
our results may help to envisage complementary therapeutic strategies to treat these 
diseases by using therapeutic tools that are already within our reach. 
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FIGURE LEGENDS 
 
FIGURE 1. Activation of MAPKs by tBuOOH, and its dependency on cPKC. (A) Time 
dependency of activation by tBuOOH (tBu) of the MAPKs, ERK1/2 (left panel), JNK1/2 
(central panel), and p38MAPK (right panel) in primary cultured hepatocytes exposed to 
tBuOOH (100 µM), or its vehicle (DMSO), for different time periods. MAPK activation 
was inferred from an increase in the phosphorylation status of these kinases, as assessed by 
Western blotting of the phospho-(p-)MAPK forms, using total (t)-MAPK forms as loading 
control (upper panel); phosphorylation degree was calculated as the p-MAPK-to-t-MAPK 
ratio for each experimental condition (lower panel), referred to control values. (B) 
Representative western blottings (upper panel) and densitometric analysis showing the 
dependency on cPKC activity of the activation of MAPKs by tBuOOH, as assessed by 
exposing primary cultured hepatocytes to the PKC inhibitors Gö6976 (Gö, 1 µM) or BIM-1 
(100 nM) for 15 min, and then exposed to tBuOOH (100 µM) for a further 15-min period. 
Control group received only Gö/BIM-1 and tBuOOH vehicle (DMSO). The results are 
mean ± S.E.M., from 4 independent experiments. aSignificantly different from control (p < 
0.05); bSignificantly different tBuOOH-treated hepatocytes (p < 0.05). 
 
FIGURE 2. Protective effect of MAPK inhibitors on the altered Bsep and Mrp2 function 
induced by tBuOOH in IRHCs. Changes induced by tBuOOH (100 µM) in canalicular 
vacuolar accumulation (CVa) of the Bsep substrate CGamF (left panel) and the Mrp2 
substrate GS-MF (right panel), in the absence or presence of the ERK1/2 inhibitor 
PD098059 (PD, 5 µM and 50 µM), the JNK1/2 inhibitor SP600125 (SP, 1 µM), or the 
p38MAPK inhibitor SB203580 (SB, 1 µM). IRHCs were pretreated for 15 min with the 
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MAPK inhibitors, or with their respective vehicles in the control group, and then with 
tBuOOH (100 µM) for a further 15-min period. Finally, IRHCs were exposed for an 
additional 15-min period to CGamF or CMFDA, a metabolic precursor of GS-MF. The 
canalicular accumulation was expressed as the percentage of the total number of IRHCs 
present in the field showing visible apical CGamF- or GSMF-associated fluorescence, 
referred to control values. At least 200 IRHCs were analyzed in each group (n = 6). Values 
are mean ± S.E.M. aSignificantly different from the control group (DMSO) (p <0.05); 
bsignificantly different from tBuOOH group (p <0.05).  
 
FIGURE 3. Protective effect of MAPK inhibitors on the changes in Bsep and Mrp2 
localization induced by tBuOOH in IRHCs. Confocal images showing localization of (A) 
Bsep and (B) Mrp2, after exposure to tBuOOH (100 µM) for 15 min, in the absence or 
presence of the ERK1/2 inhibitor PD098059 (PD, 50 µM), the JNK1/2 inhibitor SP600125 
(SP, 1 µM), or the p38MAPK inhibitor SB203580 (SB, 1 µM), administered 15 min before 
addition of tBuOOH; insets are the corresponding differential interface contrast (DIC) 
images. After these treatments, IRHCs were fixed and immunostained for Bsep or Mrp2, as 
described in Materials and Methods. Location of the transporters was evaluated by image 
analysis of the photographs obtained, by assessing the distribution pattern of fluorescence 
intensity along an axis perpendicular to the canalicular vacuole (4 µm to each side of the 
canalicular center), using the image analysis program Image J 1.34m software 
(Improvision, Coventry, NIH). Statistical analysis of the fluorescence profiles showed a 
significant change in tBuOOH-treated IRHCs (p < 0.05; number of canalicular vacuoles 
analyzed > 10, from 3 independent experiments per group), with a decrease in the 
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fluorescence intensity in the canalicular area, together with an increased fluorescence at a 
greater distance from the canalicular vacuole, which was counteracted by the MAPK 
inhibitors. 
 
FIGURE 4. Effect of MAPK inhibitors on tBuOOH-induced blebbing and disruption of 
F-actin cytoskeleton in IRHCs. (A) Bleb formation and (B) changes in F-actin distribution 
after exposure to tBuOOH (100 µM) for 15 min, in the presence or absence of the ERK1/2 
inhibitor PD098059 (PD, 50 µM), the JNK1/2 inhibitor SP600125 (SP, 1 µM), or the 
p38MAPK inhibitor SB203580 (SB, 1 µM), administered 15 min before tBuOOH addition. 
Bleb formation was assessed by phase-contrast microscopy. F-actin distribution was 
assessed by staining with fluorescently-labeled phalloidin, followed by confocal 
microscopy and further image analysis for quantification of the proportion of fluorescence 
intensity localized in the pericanalicular zone. The number of IRHCs analyzed per group 
was > 30, obtained from a minimum of 3 independent preparations. Values are mean ± 
S.E.M. aSignificantly different from control group (p <0.05); bSignificantly different from 
tBuOOH-treated group (p <0.05). 
 
FIGURE 5. Effect of MAPK inhibitors on tBuOOH-induced alterations in biliary 
secretory function in PRLs. Sequential changes in (A) bile flow, (B) bile salt output, and 
(C) DNP-SG output, in in situ PRLs exposed to tBuOOH (75 µM) for 10 min, in the 
presence or absence of the ERK1/2 inhibitor PD098059 (PD, 5 µM), the JNK1/2 inhibitor 
SP600125 (SP, 1 µM), or the p38MAPK inhibitor SB203580 (SB, 250 nM), administered 
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15 min before tBuOOH. Data are expressed as mean ± S.E.M. aSignificantly different from 
control; bSignificantly different from tBuOOH (p < 0.05, n = 5). 
 
FIGURE 6. Prevention by MAPK inhibitors of Bsep/Mrp2 endocytic internalization and 
F-actin cytoskeleton disruption induced by tBuOOH in PRL experiments. Representative 
confocal images illustrating the endocytic internalization of Bsep and Mrp2, together with 
the disruption of F-actin cytoskeleton induced by tBuOOH (75 µM, 10 min), and its 
prevention by the ERK1/2 inhibitor PD098059 (PD, 5 µM), the JNK1/2 inhibitor SP600125 
(SP, 1 µM), or the p38MAPK inhibitor SB203580 (SB, 250 nM), administered 15 min before 
tBuOOH (or DMSO in controls). Images were taken 20 min after the onset of perfusion 
with tBuOOH. (A) Co-staining of Bsep (green) and F-actin (red); (B) Co-staining of Mrp2 
(green) and F-actin (red). In control livers, both Bsep and Mrp2 were mainly confined to 
the canalicular space, whereas in livers treated with tBuOOH, relocalization of intracellular 
fluorescence associated with both Bsep and Mrp2 from the canalicular space to the 
pericanalicular area was apparent, thus indicating endocytic internalization of the 
transporters. The MAPK inhibitors prevented this phenomenon, as illustrated by a control-
like pattern of the Bsep and Mrp2 distribution in livers preperfused with the MAPK 
inhibitors. Regarding cytoskeleton integrity, pericanalicular localization of F-actin was 
evident in control livers, while a severe disarrangement of F-actin was observed in livers 
perfused with tBuOOH. MAPK inhibitors partially prevented tBuOOH-induced 
disturbances on F-actin cytoskeleton, thus explaining their protective effects on canalicular 
transporter localization and function. 
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